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Kurzreferat: 
Das proinflammatorische Interleukin(IL)-1ß und sein korrespondierender Rezeptor 
IL-1RN spielen eine entscheidende Rolle bei der mukosalen Inflammation im 
Rahmen einer H. pylori Infektion. Das Ziel dieser Arbeit war es zu untersuchen, ob 
spezifische Polymorphismen mit einem erhöhten Magenkarzinom(Ca)risiko und 
seiner premalignen mukosalen Veränderungen (atrophische Gastritis) in Peru 
einhergehen. Dafür wurde eine hospital-based Fall-Kontroll Studie mit 658 
prospektiven Patienten durchgeführt, wovon 419 für die statische Auswertung 
eingeschlossen werden konnten. 
In der Studien-Population zeigte sich, dass Individuen die das C Allele des IL-1B-
511 SNP tragen, ein erhöhtes Risiko sowohl für die chronisch-atrophische 
Gastritis (P=0,001) als auch für das Magen-Ca (P=0,002) besitzen. Im Vergleich 
dazu stand der IL-1RN- Polymorphismus in keinem Zusammenhang mit einem 
erhöhten Risiko, weder für das Magen-Ca noch der chronisch-atrophischen 
Gastritis.  
 
Schlüsselwörter: [IL-1B Polymorphismus], [H. pylori Infektion], [Gastritis],  
 [Magenkarzinom], [PERU] 
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 8 zusammenfassung 
1 ZUSAMMENFASSUNG 
EINLEITUNG: Das proinflammatorische Interleukin(IL)-1ß und sein 
korrespondierender Rezeptor IL-1RN spielen eine entscheidende Rolle bei der 
mukosalen Inflammation im Rahmen einer H. pylori Infektion. Polymorphismen im 
IL-1RN Gen und in der Promotor-Region von IL-1B-511 haben eine veränderte              
IL-Produktion zur Folge und führen zu einer verminderten intragastralen 
Säureproduktion. Das ZIEL der Studie war es zu untersuchen, ob spezifische 
Polymorphismen mit einem erhöhten Magenkarzinom(Ca)risiko in Peru 
einhergehen, da Peru i) eine hohe Prävalenz der H.- pylori- Infektion, ii) eine hohe 
jährliche Inzidenz von Magen-Ca & iii) einen gemischten genetischen Pool in der 
Bevölkerung durch Immigration von Europäern, Asiaten, Nord-amerikanern & 
Amerindern aufweist.  
MEDOTHIK: Es wurde eine hospital-based Fall-Kontroll Studie mit 658 prospektiven 
Patienten durchgeführt, wobei 419 Patienten in die statische Auswertung 
eingeschlossen werden konnten. Patienten mit nicht-atrophischer Gastritis (NAG, 
n= 158) dienten als Kontroll-Gruppe und wurden im Verhältnis 2:1 zu Patienten mit 
chronisch atrophischer Gastritis (ChAG, n=43) und im Verhältnis 1:1 zu Individuen 
mit Magenkarzinom (GC, n= 133) anhand von Alter, Geschlecht und ausgesetzten 
Umweltfaktoren zugeordnet. Eine H. pylori Infektion wurde durch histologische 
Untersuchung, PCR Technik und Kultivierung aus endoskopisch gewonnenen 
Biopsien nachgewiesen. Mittels PCR und Restriktion Fragmentanalyse (RFLP) 
wurden die Patienten erfolgreich für den IL-1B-511 SNP und der various number 
tandem repeat (VNTR) des IL-1RN genotypisiert. 
ERGEBNISSE: Mit Hilfe konditional logistischer Regressionsanalyse zeigte sich in 
der untersuchten Population, dass der homozygote Genotype des IL-1B-511 C 
Alleles signifikant häufiger bei chronisch-atrophischer Gastritis (Odds Ratio [OR] = 
11,2; 95 % Konfidenzintervall [CI] = 2.27-55.57) und Magen-Ca (OR = 4,15; 95 % 
CI = 1,33-12,93) auftrat als bei Patienten mit nicht-atrophischer Gastritis. Damit 
verbunden war ein knapp 6-fach erhöhtes Risiko für ein intestinales Magen-Ca im 
Corpus Bereich (OR = 6,3; 95 % CI 1,17-33,76) bei homozygoten C Allel Träger 
des IL-1B-511 SNP im Vergleich zu Kontroll-Patienten mit homozygoten T Allel 
Status. Im Vergleich dazu zeigte sich keine Assoziation zwischen dem IL-1RN-
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Polymorphismus und einem erhöhten Risiko, weder für das Magen-Ca noch der 
chronisch-atrophischen Gastritis.  
SCHLUSSFOLGERUNG: Das C Allel des IL-1B-511 SNP ist mit einem erhöhten Risiko 
sowohl für die chronisch-atrophische Gastritis als auch für das Magen-Ca in Peru 
verbunden. Wegen der hohen Prävalenz einer H. pylori Infektion kann der           
IL-1B-511 SNP ein Indikator für Patienten sein, die von einer umfangreichen 
Eradikationstherapie und intensiver, endoskopischer Überwachung von 
Mukosaveränderungen im Magen profitieren würden. In Studien mit Kaukasiern 
wurde das T- Allel mit einem erhöhten Magen-Ca-Risiko in Verbindung gebracht. 
Die vorliegenden Ergebnisse korrelieren mit Studien aus Asien, was auf eine 
populationsabhängige Assoziation hindeutet. Damit wird die Wichtigkeit 
vergleichender molekularbiologisch-epidemiologischer Studien deutlich, um 
Risikofaktoren in einer Population zu identifizieren. 
 
Schlüsselwörter: [IL-1B Polymorphismus], [H. pylori Infektion], [Gastritis], 
 [Magenkarzinom], [PERU] 
 
 
2 SUMMARY 
BACKGROUND AND AIMS: It has recently been suggested that interaction between 
bacterial virulence factors and immune response of the host affect the outcome of 
H. pylori infection and may be influenced by polymorphisms in both, bacterium and 
host. Especially polymorphisms in IL-1B and IL-1RN genes were found to be 
associated with higher risk for gastric cancer development due to increased IL-1ß 
level in gastric mucosa in response to H. pylori infection. This thesis examines the 
relationship between proinflammatory interleukin gene polymorphisms, risk of 
chronic atrophic gastritis and gastric cancer in a developing country of South 
America with a high prevalence of H. pylori. 
METHODS: A hospital-based case-control study among 658 prospectively recruited 
patients was conducted and 419 patients were included for further statistical 
analysis. Patients with non-atrophic gastritis (NAG, n=158), served as controls and 
 10 summary 
were matched 2:1 to patients with chronic atrophic gastritis, a premalignant lesion 
(ChAG, n=43) and 1:1 to subjects with gastric cancer (GC, n=133). Several 
biopsies were obtained endoscopically and H. pylori infection was determined by 
histological examination, PCR and cultivation. Patients were successfully 
genotyped for the IL-1B–511 SNP and the various number tandem repeats 
(VNTR) of the IL-1RN by using PCR and RFLP technique.  
RESULTS: Using conditional logistic regression analysis adjusted for H. pylori 
infection, we demonstrated that homozygote C allele carriers of the IL-1B-511 
SNP are associated with an increased risk for atrophic gastritis (odds ratio [OR], 
11.2; 95 % confidence interval [CI], 2.27-55.37) and gastric cancer (OR, 4.15;     
95 % CI, 1.33-12.93) as compared with the homozygote T allele variant. 
Stratification by location and subtype of gastric cancer in an unconditional logistic 
regression analysis revealed a higher risk for intestinal type of gastric cancer (IT-
GC) in the corpus (OR, 6.3; 95 % CI, 1.2-33.8) for homozygous C allele carriers of 
the IL-1B-511 SNP. A higher risk was found for atrophic gastritis in the antrum 
region for the homozygous variant of the IL-1B-511 C allele (OR, 12.7; 95 % CI, 
2.12-76.43). In comparison, the IL-1RN polymorphism was not associated with an 
increased risk for either gastric cancer or chronic atrophic gastritis in Peru. 
CONCLUSION: This study is the first to verify the C allele of the IL-1B-511 SNP as a 
risk factor in a population from South-America. Similar to a population of China 
and unlike studies conducted with Caucasians, the C allele of the IL-1B-511 SNP 
appears to predispose individuals to ChAG and IT-GC. In view of a high H. pylori 
prevalence and a high recurrence rate of treated infection in Peruvians, IL-1B-511 
SNP might be an indicator for patients who could benefit from rigorous anti H. 
pylori therapy and intensive monitoring of their gastric mucosal changes by 
intermittent gastroscopies. The findings suggest that the SNP in IL-1B-511 is a 
population-dependent risk factor and is involved in genetically predisposing for 
chronic atrophic gastritis and intestinal type of gastric cancer in Peru. 
 
 Key words: [IL-1B polymorphisms], [H. pylori infection], [Gastric cancer], 
            [Gastritis], [PERU] 
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3  ABBREVIATIONS 
bp 
cagA 
ChAG 
CI 
DNA 
dNTP’s 
DT-GC 
EDTA 
EthBr 
Hp, H. pylori 
HWE 
IL-1B 
IL-1ß 
IL-1RN 
IL-1ra 
INEN 
IT-GC 
LOAYAZA  
OR 
NAG 
PCR 
PMNs 
RFLP 
ROS 
RUT 
SNP(s) 
UV  
vacA 
WHO 
Base pair 
Cytotoxicity associated gene A 
Chronic atrophic gastritis 
Confidence interval 
Desoxyribonucleic acid 
Desoxynucleictriphosphates 
Diffuse type of gastric cancer 
Ethylendiamintetraacetate 
Ethidium bromide 
Helicobacter pylori 
Hardy-Weinberg Equilibrium 
Interleukin-1-beta gene 
Interleukin-1-beta protein 
Interleukin-1 receptor antagonist gene 
Interleukin-1 receptor antagonist protein 
Instituto Especializado de Enfermedades Neoplasicas 
Intestinal-type gastric cancer 
Hospital Arzobispo Loayaza 
Odds ratio 
Non- atrophic gastritis 
Polymerase chain reaction 
Polymorphonuclear neutrophils 
Restriction fragment length polymorphism 
Reactive oxygen species 
Rapid urease test 
Single Nucleotide Polymorphism(s) 
Ultraviolet  
Vacuolating cytotoxin-A 
World Health Organization 
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4 INTRODUCTION 
4.1 GASTRIC CANCER 
While substantial efforts have been made to diagnose and treat gastric cancer, 
each year 870,000 new cases of stomach cancer are diagnosed worldwide, and it 
accounts for over 650,000 deaths annually [1]. The incidence differs greatly 
between Western countries and other parts of the world, and is highest in Japan, 
South America, Eastern Europe, and parts of the Middle East. Parkin et al. 
showed that 60 % of new gastric cancer cases occur in developing countries [2].  
 Worldwide, adenocarcinomas rank among the most frequent forms of 
gastric cancer (85 %) with approximately 40 % at the pylorus, 40 % within the 
corpus segment and 15 % at cardia. Due to asymptomatic or non-specific 
symptoms in its early stages, gastric cancer has usually already metastasized by 
the time symptoms occur, which is a reason for its poor prognosis. According to 
Lauren’s classification, the histological distinction can be made between intestinal-
type gastric cancer (IT-GC) and diffuse-type gastric cancer (DT-GC).  
 Depending on glandular architecture and cellular pleomorphisms, the 
intestinal-type gastric cancer is distinguished by 3 degrees of differentiation (good, 
moderate and poor). A multi-step process involving a progressive cascade of 
molecular and morphological changes has been proposed by Correa for the 
development of intestinal gastric cancer [3]. In this regard, intestinal metaplasia 
and atrophic gastritis are considered to be a background for intestinal-type 
carcinomas supported by epidemiological surveys [4-6]. 
 In contrast, diffuse-type gastric cancer has no known pre-malignant 
precursor lesions as described for intestinal-type gastric cancer. Diffuse-type 
adenocarcinoma resembles signet-ring cell carcinoma as it is classified by WHO 
classification. Secreted mucus by tumor cells is delivered into the interstitium 
where large pools of mucus/colloid are produced which appear optically as empty 
spaces. Signet-ring cells emerge when the mucus remains inside the tumor cell. 
Furthermore, it is a poorly differentiated type of cancer and tumor cells 
metastasize by loss of adhesion to neighbouring cells. 
 intr
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4.2.1 LIMA 
Most residents of Lima, the capital town of Peru with almost 9 million inhabitants, 
belong to the group of Mestizos, a mixture of European and Amerindian 
background. Lima consists of more than 30 districts which differ greatly in 
infrastructure, public water supply, energy access, sewage system and waste 
disposal. Shantytowns, known locally as asentamiento humano, consist of informal 
and unguided construction of huts with absence of public sanitation and electricity 
(Figure 4.2.a).  
 
  
(a)     (b)  
 
Figure 4.2:  Informal, unguided house and hut construction in a shantytown district 
“asentamiento humano” of Lima (a). Rural areas are located in outlying 
districts of Lima and comparable with shantytowns with regards to living 
circumstances (b). 
 
Rural areas, located in outlying districts of Lima, are comparable with shantytowns 
with regards to sanitary facilities and electricity (Figure 4.2.b). People of low 
socioeconomic status live in these areas and have no prospect of better living 
conditions due to limited funds. In contrast, residents with a higher annual income 
are able to live in districts where water is supplied by the Lima municipal system, 
waste is removed in a scheduled manner and house construction is comparable to 
standards of western countries. 
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Interestingly, the incidence of gastric cancer in Lima was found to be related 
directly with low socioeconomic level [8;10]. This suggests involvement of 
environmental factors in carcinogenesis. Even the WHO mentioned in the 2003 
World Cancer Report that environmental factors are implicated in the cause of the 
majority of human cancers [11].  
4.2.2 H. PYLORI INFECTION 
Since the rediscovery of H. pylori by Warren in 1979, infection with this bacterium 
has been linked to several types of gastric cancer, including gastric 
adenocarcinoma and gastric lymphoma. Over 50 % of the world population 
harbours this bacterium but only a small proportion of infected individuals develop 
gastric cancer. Uemura et al. showed in a study with 1,246 endoscopically 
followed patients infected with H. pylori for an average of 7.8 years that only 3 % 
of them developed gastric cancer [12].  
 H. pylori is a genetically diverse bacterium with different strains 
subdivided by their expression of cagA and vacA. Individuals infected with cagA-
positive H. pylori strains showed an increased risk for the development of gastric 
cancer [13]. However, in Peru around 85 % of the isolated H. pylori strains from 
previous sequencing studies were positive for proteins vacA and cagA, and no 
differences were found between patients with gastritis or gastric cancer [B. 
Velapatiño and R. H. Gilman, unpublished data]. Thus, it is quite plausible that 
other factors play an important role in Peruvians regarding the emergence and 
progression of precursor lesions (i.e. chronic atrophic gastritis, intestinal 
metaplasia, and dysplasia) that can lead to gastric cancer. 
 Nearly 90 % of adults in Peru undergoing upper-gastrointestinal 
endoscopy for dyspeptic symptoms are found to be infected with this       
bacterium [14;15]. In contrast, less than 25 % of young adults in North America 
and Western European countries carry H. pylori [16;17]. The high risk of this 
bacterial infection, relative to industrialized countries, is especially apparent in 
childhood. About one-half of Peruvian children become infected with H. pylori 
during their first years, and most others become infected within the following one 
to two decades [18;19]. 
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Furthermore, H. pylori reinfection rate is very high in Peruvian adults after 
successful treatment with an antibiotic eradication regime [20;21]. Since infection 
of H. pylori starts in early ages and reinfection rate is high, this bacterium 
colonizes stomach mucosa for a long period of time in Peruvians. 
 Response to H. pylori infection comprised of an inflammatory and an 
immune component, characterized by cellular infiltration lead to chronic gastritis 
more or less pronounced. In addition, it has been shown that H. pylori infection 
increases mRNA level of IL-1B gene product and that gastric pH is more alkaline 
than in uninfected patients [22;23]. Previously, it was shown that gastric epithelial 
damage by H. pylori leads to a compensatory increase in mucosal proliferation in 
the antrum and corpus and that eradication of bacterial infection decreased the 
cell proliferation levels to normal after four weeks [24;25]. Cell proliferation 
returned to its previously high level in patients, in whom eradication had failed. 
Taken together, H. pylori and IL-1ß can lead to increased cell proliferation. An 
increased cell turnover itself might make the mucosa more vulnerable to 
mutagenic effects and toxic products in the inflamed stomach. 
 Along with the bacterium, cytokines and chemokines play a part in 
maintaining gastric mucosal inflammation and may have a significant impact in 
histopathological changes of gastric mucosa which apparently represent a 
continuum of changes from normal mucosa to carcinoma. Thus, inter-individual 
differences of cytokine production, which might be genetically determined, can 
play a decisive role in cancer susceptibility when H. pylori infection occurs.  
 
 
4.3 POLYMORPHISMS IN THE IL-1 GENE 
 CLUSTER 
 
Genotype polymorphism is one of the molecular mechanisms that could cause an 
alteration in the expression and secretion of cytokines and could, therefore, play a 
crucial role in mediating different outcomes of H. pylori infection. Polymorphism 
can only affect a single nucleotide in a specific sequence and is therefore called as 
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single nucleotide polymorphism (SNP). It can occur by base substitution, insertion 
or deletion. 
 In addition, polymorphism can be related to a whole nucleotide sequence 
(10-100 nucleotides) that varies in the number of repetition (2-40 repetitions) and 
therefore entitled variable numbers of tandem repeat” (VNTR). Genetic variations 
are referred to as polymorphism once the frequency accounts to more than 1 % 
within a population. 
 SNPs make up to 90 % of all human genetic variations and can occur in 
coding and non-coding regions of genes, owing to the accidental manner of 
mutations. Due to the redundancy in the genetic code, SNPs within a coding 
sequence will not necessarily change the primary sequence of a protein or its 
function. Essentially, SNPs in non-coding regions can have consequences for 
gene splicing, binding of transcription factors or regulation of transcription with an 
alteration of the mRNA level. In this regard, a functional polymorphism denotes for 
instance an increased IL-1β production. This have been reported for a single 
nucleotide change at −511 positions [26] that is termed as IL-1B-511 SNP. The 
location of -511 represents a position 511 base pairs upstream of the promoter- 
starting site (Figure 4.3) and may manipulate a putative transcription factor binding 
site. 
 
 
 
Figure 4.3: SNPs in the IL-1 gene cluster. 
 Overview of the IL-1 gene cluster with the SNPs in the IL-1B promoter 
region at position -511 and the variable number of tandem repeats (VNTR) 
in intron 2 of the IL-1RN gene. 
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IL-1ß plays an important role in the regulation of inflammatory responses, since it 
induces gene expression of other inflammatory cytokines. Beside the regulative 
role of IL-1ß in transcription, it also acts by inducing the proliferation of gastric 
epithelial cells in culture [27] and inhibiting the secretion of gastric acid [28]. A 
profound inhibition of the acid level raises the pH in the gastric mucosa and is 
responsible for progressive atrophy in the stomach [29]. The crucial role of IL-1ß to 
gastric acid output in stomach and subsequent progression to gastric cancer has 
been demonstrated with a transgenic mouse model. Overexpression of IL-1ß in 
gastric mucosa leads to lower gastric acid levels accompanied with severe 
gastritis followed by mucosal changes and adenocarcinoma [30;31]. However, the 
underlying mechanism of altered production of the proinflammatory IL-1ß cytokine 
by the IL-1B-511 SNP is not fully understood. 
  
 The effects of IL-1ß are mediated by its corresponding receptor (IL-1R) 
and subsequent activation of internal cell pathways. IL-1ra (gene, IL-1RN) shows 
the same affinity to the IL-1 receptor but does not induce any intracellular 
response. Thus, IL-1ra acts as a competitive inhibitor and subsequently modulates 
the proinflammatory effects of IL-1ß [32]. The IL-1RN gene contains a repetitive 
element of 86 bp (VNTR) in intron 2 (Figure 4.3 and 4.4), and at least 5 alleles of 
this polymorphism exist in human populations. A particular allele of this IL-1RN 
VNTR polymorphism (i.e. IL-1RN *2 allele) has been associated with a more 
severe clinical outcome in several diseases having an inflammatory component. 
The IL1RN *2 allele (2 repetitions) is associated with increased IL-1ß production         
in vitro [33]. Subjects with this proinflammatory genotype and H. pylori infection 
showed increased production of IL-1ß which leads to increased gastric 
inflammation, gastric atrophy and risk for developing gastric cancer [34]. 
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Figure 4.4:  Overview of IL-1RN VNTR. The Intron 2 of the IL-1RN gene contains a 
penta-allelic 86-bp tandem repeat (VNTR, variable number of tandem 
repeats). Detection of genotype was carried out with PCR technique. 
 
2.4 STUDIES 
Since El-Omar et al. have reported a strong association between the IL-1B-511 
SNP and the risk of gastric cancer [26;35], several studies were conducted to shed 
light on the impact of this single nucleotide exchange in different populations. 
Consistent associations between gastric disease and allele polymorphisms have 
been found for IL-1B-511*T (T allele) and/or IL-1RN*2 (*2 allele) carriers among 
Caucasians [26;35-43] and also among Asians [44-47]. However, not all of the 
subsequent studies were able to find an association between the distinct IL-1 gene 
polymorphisms and gastric cancer. In particular, further studies from Asia [29;48-
57] failed to show an association compared to studies from Western          
countries [58;59].  
 Interestingly, a study from China reported unequal associations between 
IL-1B-511 alleles and gastric cancer risk even in the same population depending 
on the cancer prevalence [45]. Thus, a significant association between the IL-1B-
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 22 aim of the study 
5 AIM OF THE STUDY 
 
The aim of this study was to investigate whether or not alleles of the cytokine      
IL-1B gene (site -511) and of the IL-1 receptor antagonist (IL-1RN) are associated 
with an increased risk for chronic-atrophic gastritis or gastric cancer in the 
Amerindian population of Peru.  
  
 
 
In particular, this thesis specifically aimed to find out whether:  
 
 
1. There is a marked difference in the frequency of the investigated alleles in 
patients with gastric cancer compared with subjects having non-atrophic gastritis;  
 
2. There is a difference between intestinal-type and diffuse-type gastric cancer 
with regards to the association to the distinct alleles in the IL-1 gene cluster; 
 
3. The alleles show an association with the development of chronic atrophic 
gastritis, a known precursor lesion for intestinal-type gastric cancer; 
 
4. Chronic-atrophic gastritis and gastric cancer arise predominantly at one site in 
the stomach in association with a distinct allele of the IL-1 gene cluster.  
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6 MATERIALS AND METHODS 
6.1 MATERIALS 
6.1.1 ASSAYS AND KITS 
QIAamp DNA Mini kit Qiagen, Valencia, CA, USA 
Gram stain kit BD Biosciences, San Jose, CA, USA 
6.1.2  SUBSTANCES 
Primer Invitrogen, Carlsbad, CA,USA 
Acetic acid Sigma, St. Louis, MO, USA 
Agarose gel (UltraPure) Invitrogen, Carlsbad, CA,USA 
AvaI restriction enzyme NEB-Labs, Beverly, MA, USA 
Bacto agar BD & Co., Sparks, MD, USA 
BHI agar and CNA agar BD & Co., Sparks, MD, USA 
BSA Sigma, St. Louis, MO, USA 
Cresol red Sigma, St. Louis, MO, USA 
DNA ladder (100 bp) Invitrogen, Carlsbad, CA,USA 
EDTA Invitrogen, Carlsbad, CA,USA 
Ethanol 96 % Sigma, St. Louis, MO, USA 
Ethidium bromide (1 mg/ml) Fisher Scientific, NJ, USA 
Gelatin Centerchem, Norwalk, CT, USA 
Glacial acetic acid Sigma, St. Louis, MO, USA 
Glycerol Sigma, St. Louis, MO, USA 
Haematoxylin and eosin solution Sigma, St. Louis, MO, USA 
Hydroquinone Calbiochem, San Diego, CA, USA 
Nucleotide mix Invitrogen, Carlsbad, CA,USA 
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Proteinase K  Sigma, St. Louis, MO, USA 
Silver nitrate Res. Organics, Cleveland, OH, USA 
Sodium acetate Calbiochem, San Diego, CA, USA 
Taq DNA polymerase (recombinant) Invitrogen, Carlsbad, CA,USA 
Tris base Sigma, St. Louis, MO, USA 
Urea agar base BD & Co., Sparks, MD, USA 
6.1.3  EQUIPMENT 
BBL Campy Pouch  
microaerophilic system 
 
BD & Co., Sparks, MD, USA 
DC 120 camera with frame grabber Kodak, Rochester, NY, USA 
Dell workstation Dell, Round Rock, TX, USA 
Endoscope Fujinon EG450 HR Olympus, Lima, Peru 
Laminar flow hood, (NUAIRETM) NUAIRE, Plymouth, MN. USA 
Microcentrifuge VSMC-13 ProScientific, Oxford, CT, USA 
Microwave (Sharp Carousel) Sharp, Romeoville, IL, USA 
Petri dishes (100 x 55 mm) Fisher Scientific, Pittsburg, PA, USA 
Seal-Rite 1.5 ml Eppendorf tube USAScientific, Ocala, FL, USA 
Tissue grinder Bioworld, Dublin, OH, USA 
UV illuminator Kodak, Rochester, NY, USA 
Vortex (Vortex Genie 2) Bohemia, NY, USA 
Water bath (Lab-Line 18020) MIDSCI, St. Louis, MO, USA 
6.1.4  SOFTWARE 
Kodak digital science 1D software Kodak, Rochester, NY, USA 
SPLUS (Version 2000) Insightful Corporation, Seattle, WA, USA 
SPSS for Windows (Version 11.5) SPSS Science, Chicago, IL, USA 
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6.2  METHODS 
6.2.1  SETTING AND PATIENTS 
A hospital-based case-control study was conducted between January 2005 and 
December 2006. All enrolled patients (over 18 years of age) had been i) newly 
hospitalized in two municipal hospitals of Lima/Peru (South America) and             
ii) undergone endoscopy of the upper gastrointestinal tract (inclusion criteria). 
Exclusion criteria were previous gastrectomy, concomitant major diseases, clinical 
cancer history, cardia cancer, atypical gastric cancer, MALT lymphoma, uncertain 
diagnosis or pregnancy.  
 Due to high rates of chronic H. pylori infection in Peru (in over 90 % of 
adults in lower socioeconomic classes) gastric biopsies without gastritis, typical of 
modern industrialized societies, are a rarity. Thus, patients with non-atrophic 
gastritis were used as the reference control group. Controls were frequency-
matched to cases with respect to age (± 10 year), gender and environmental risk 
factors (housing material, water preparation, waste), showing significant 
differences between controls and cases. For cases with incident non-cardia gastric 
cancer (intestinal-type and diffuse-type), controls were matched 1:1; for cases with 
chronic atrophic gastritis, controls were matched 2:1.  
 All participants gave written consent for participation in this research study 
and were interviewed using a 130-item questionnaire that included personal 
characteristics, environmental risk factors, personal and family medical history. 
EDTA blood samples (4 ml) were obtained and stored at -20 °C for subsequent 
DNA extraction. 
The study was in accordance with guidelines of the Declaration of Helsinki 
for Biomedical Research and was approved by the institutional ethics committees 
of The Johns Hopkins School of Public Health (Baltimore, MD, USA), and 
Associación Benéfica PRISMA (Lima, Peru). 
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6.2.2  ENDOSCOPIC ASSESSMENT 
All endoscopic examinations were routinely performed under mild sedation using 
an endoscope (Fujinon). For optimal assessment, specimens were taken as 
follows and shown in Figure 6.7: 
- From the antrum within 2 to 3 cm orally from the pylorus: Greater (A1) 
and lesser (A2) curvature, respectively; n=2, 
- From the corpus about 8 cm aborally from the cardia: Greater (C1) 
and lesser (C2) curvature, respectively; n=2, 
- One from the incisura angularis (IA) along with all visible lesions, 
n=1+x 
 
Figure 6.7: Schematic representation of the biopsies taken from each patient. One 
biopsy was taken from each site in the stomach, namely greater curvature 
of antrum (A1) and corpus (C1), lesser curvature of antrum (A2), corpus 
(C2), and incisura angularis (IA). 
 
At least 3 biopsies along with all additional biopsies from visible lesions were 
subjected to histological preparation; one biopsy per patient was storage used for 
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culture and PCR essays. All samples were coded for anonymity and stored before 
processing for further investigation. 
6.2.3 MOLECULAR BIOLOGICAL METHODS 
6.2.3.1 DNA EXTRACTION  
One biopsy from gastric antrum was mechanically ground using tissue grinder 
(Bioworld) in a 1.5 ml Eppendorf tube and lysed by adding 100 µl ATL and 20 µl 
proteinase K with subsequent incubation at 56 °C for 3 hours. The incubated 
mixture was occasionally vortexed to disperse the sample. 200 µl AL buffer was 
added and the sample was pulse-vortexed for 15 s and incubated at 70 °C for 10 
minutes DNA was then precipitated by adding 200 µl of 96 % ethanol, pulse-
vortexed for 15 s and applied to a spin column, as provided in the manufacturer’s 
kit. During centrifugation at 6,000 g for 1 min, DNA was bound by a silica 
membrane of the spin column which separated genomic DNA from other extracts 
of the tissue. DNA bound by the silica membrane of the spin column was washed 
with 500 µl AW buffer and centrifuged at 6,000 g for 1 min. The wash step was 
repeated and the spin column was centrifuged at 10,000 g for 3 min. Finally, the 
DNA was eluted in a fresh 1.5 ml Eppendorf tube by centrifugation at 6,000 g for 1 
min using pre-warmed 200 µl AE buffer. Extracted DNA was used to determine the 
genotype of IL-1B-511, IL-1RN and for H. pylori detection. For long-term storage, 
DNA was stored at -20 °C. When extracted DNA from biopsy yielded limited 
amount, stored blood samples from patients were used for DNA extraction. 
 
6.2.3.2 POLYMERASE CHAIN REACTION  
Over the past 20 years, PCR has become a standard technique to enzymatically 
amplify specific genome sequences. Three steps are required which are repeated 
several times and carried out using a PCR cycler machine. Starting at 95 °C, the 
double-stranded DNA denatures and primer can anneal in the second step, which 
must be optimized for each primer. For amplification, the Taq polymerase starts on 
the 3’ end of each primer and adds dNTP’s, reading the template from 5’ to 3’ at 
72 °C. To perform several parallel reactions, a stock solution containing water, 
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buffer, dNTP’s, primers and Taq-DNA polymerase was prepared in a single tube 
and then aliquoted into individual tubes. 2 µl of DNA from each patient was added 
and PCR, optimized for each primer (Table 6.1), were carried out on a PCR cycle. 
 
 Table 6.1. Primers for PCR 
Primer  
(PCR product) Tm
a  Sequence 5‘- 3‘ 
IL-1B-511 50 °C Sb TGG CAT TGA TCT GGT TCA TC 
(305 bp)  Ac GTT TAG GAA TCT TTC CCA CTT 
IL-1RN 55 °C S CTC AGC AAC ACT CCT AT  
(3 products)*  A TCC TGG TCT GCA GGT AA  
UreB 67 °C S CGT CCG GCA ATA GCT GCC ATA GT 
(436 bp)  A GTA GGT CCT GCT ACT GAA GCC TTA 
a Annealing temperature, b Sense primer, c Anti-sense primer 
* 412 bp (four repeats: *1 allele), 240 bp (two repeats: *2 allele), 326 bp (three repeats: 
*3 allele) 
 
6.2.3.3  GEL ELECTROPHORESIS 
Agarose is a polysaccharide that is obtained from seaweed and when dissolved 
and heated in water, it melts as crosslinks are broken. Poured into a chamber and 
cooled, the crosslinks reform and the gel is set in the shape of the gel chamber. 
Thus, a matrix with defined pore size develops, dependent on the concentration of 
agarose, and can be exposed to an electric field. DNA fragments are separated by 
size due to DNA’s negative charge in solution. Thus, large DNA molecules will 
migrate more slowly to the anode in the agarose gel in comparison to smaller 
molecules when loaded on the cathode.  
 Separated fragments can be visualized by adding ethidium bromide 
(EthBr) to agarose before gel casting. Due to the intercalating feature of EthBr, it 
binds strongly to DNA that migrates through the agarose gel in the process of 
electrophoresis. Under UV light, DNA-bound EthBr transmits energy which is 
visible as orange light. Using a 100 bp DNA molecular weight marker, the 
fragment size of the separated DNA can be determined. 
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The PCR product for IL-1RN and the RFLP for IL-1B were directly separated with 
2 % UltraPure Agarose Gel. The following solutions were prepared (Table 6.2) and 
used for agarose gel preparation (Table 6.3):  
 
 
Table 6.2. Preparation of 1 L Tris-acetate-EDTA (TAE) buffer (50X)  
Reagents Amount 
Tris base 242.0 g 
Acetic acid 57.1 ml 
0.5 M EDTA  100.0 ml 
ddH2O up to 1 L 
 
 
 
 
Table 6.3. Preparation of an agarose gel   
Reagents Final concentration 
TAE buffer (50X) 1X 
Ethidium bromide 0.13 µg/ml 
(w/v) Agarose 2 % 
 
 
 
Subsequently, bands were visualized under an UV illuminator. A digital image was 
recorded with a charged couple device (CCD) camera and frame grabber using 
Kodak digital science 1D software on a Dell workstation. A 100 bp DNA ladder 
was used as a marker.  
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6.2.3.4 THE RFLP FOR GENOTYPING THE IL-1B-511 SNP 
The restriction fragment length polymorphism (RFLP) technique utilizes the ability 
of restriction enzymes to cut double-stranded DNA containing a recognition 
sequence that is specific for each enzyme. The specific recognition sequence can 
be lost or arise spontaneously if a single nucleotide is changed at a specific site in 
the sequence. For this reason, RFLPs can be used for genotyping without 
sequencing the gene of interest. 
 
For genotyping the IL-1B-511 SNP, a 305 bp fragment was initially amplified from 
2 µl (10-20 ng) of the template DNA with PCR. 25 µl of the reaction mixture was 
prepared as follows (Table 6.5). Cresol red was used as loading dye (Table 6.4).  
 
 
Table 6.4. Preparation of loading dye cresol red 
Reagents Final concentration 
Glycerol 50 % 
Cresol red 0.01 mg/ml 
 
Table 6.5. Reaction mixture for PCR 
Reagents Final concentration in 25 µl sample volume 
PCR buffer (10X) 1X 
dNTP mix 0.25 mM 
IL-1B-511 primer (sense)  0.5 µM 
IL-1B-511 primer (antisense)  0.5 µM 
MgCL2 1.5 mM 
BSA 0.1 µg/ml 
Cresol red 0.1 mg/ml 
Taq DNA polymerase 0.06 U 
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PCR was performed using the following cycling parameters (Table 6.6):  
 
Table 6.6. PCR cycling parameters for IL-1B-511 primers 
1x Denaturation 95 °C 5 min 
30x 
 
Denaturation 95 °C 30 s 
Annealing 
Elongation 
50 °C 
72 °C 
30 s 
30 s 
1x Extenstion 72 °C 5 min 
 
 
Afterwards, a RFLP was used to detect the absence or presence of the mutation 
at the -511 site of the IL-1B gene. Restriction analysis was conducted by 
incubating the prepared reaction mixture (Table 6.7) at 37 °C for 18 h. 
 
 
Table 6.7. Reaction mixture for enzyme digestion  
Reagents Volume 
PCR product 16 µl 
AvaI enzyme (10,000U/ml) 1 µl 
Enzyme buffer  2 µl 
Water  up to 20 µl 
 
 
Figure 6.8 shows a representative RFLP of the different genotypes compared with 
a 100-bp DNA ladder to identify the molecular size of the digestion product. Either 
an intact (AvaI un-cut) fragment of 305 bp (T allele) or two (AvaI cut) fragments of 
190 bp and 115 bp (C allele) were obtained using electrophoresis. The following 
genotype notation was used: C/C (IL-1B-511 C homozygote), T/T (IL-1B-511 T 
homozygote) and C/T (IL-1B-511 heterozygote). 
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Figure 6.8: Detection of genotypes for the IL-1B-511 SNP. DNA amplicons were 
digested by the AvaI restriction enzyme, separated by gel electrophoresis 
and visualized under UV light. Three different patterns of IL-1B-511 
genotypes were classified into C/C (homozygous C allele; lane 2), T/T 
(homozygous T allele; lane 3), C/T (heterozygote; lane 4). DNA ladder (100 
bp) was used to determine the fragment size of separated DNA (lane 1). 
 
 
6.2.3.5 GENOTYPING ASSAY FOR THE VNTR IN THE IL-1RN GENE  
The diagnostic variable number of tandem repeat (VNTR) marker for IL-1RN 
alleles were genotyped by PCR with similar sample preparation and cycling 
parameters as used for IL-1B-511 genotyping but optimized with 3 mM MgCl2, and 
annealing temperatures (Tm) of 55°C for IL-1RN primers. The IL-1RN alleles were 
coded as follows: *1 allele (four repeats of the 86-bp region yields a 412-bp PCR 
product), *2 allele (two repeats, 240 bp) and *3 allele (three repeats, 326 bp).  
 For statistical analysis, this polymorphism was treated as bi-allelic using a 
short allele category with two repeats (*2 allele) and a long allele category (L 
allele) with three or more repeats (*1 allele and *3 allele). Figure 6.9 shows the 
pattern of the genotypes 1/1, 2/2, 1/2 and 3/2 compared with a 100-bp DNA 
ladder.  
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Figure 6.9: Agarose gel after electrophoresis shows different genotypes for the VNTR 
in the IL-1RN gene. Separated DNA fragment sizes were classified into 1 
(four repeats, 412 bp), 2 (two repeats, 240 bp), 3 (three repeats, 326 bp). 
For statistical analysis three or four repeats were categorized as L allele 
(homozygous L allele; lane 2) and 2 repeats as *2 allele (homozygous *2 
allele; lane 2, heterozygote; lane 4+5). DNA ladder (100 bp) was used to 
determine the fragment size of separated DNA (lane 1). 
 
 
 
6.2.3.6 INTERNAL ASSAY CONTROL 
The efficiency of each genotyping assay has a bearing on the determination of the 
genotype itself. Thus, the absence of the restriction recognition site for AvaI can 
also be due to the mal-function of the restriction enzyme. For this reason it is 
crucial to ensure that each run of an assay reveals the same results and is 
working properly.  
 To validate the performance of each assay setting for the IL-1B-511 SNP 
and IL-1RN VNTR, one fifth of samples from the preceding setting were 
reanalyzed in the subsequent run. Furthermore, several samples were sequenced 
for the polymorphism and for every assay all possible genotypes (C/C, C/T, T/T for 
the IL-1B-511 SNP and *2/*2, *2/L, L/L for the IL-1RN VNTR) served as internal 
positive controls. All results were completely concordant. 
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 6.2.4 PATHOHISTOLOGY 
One biopsy each from the antrum, corpus and incisura were fixed in 10 % neutrally 
buffered formalin, embedded in paraffin, subsequently cut in 3-µm thick sections 
and followed by haematoxylin and eosin staining for routine pathohistological 
investigation according to standard protocol. Each slide was interpreted by an 
experienced but blinded senior pathologist without knowledge of the area of origin 
of the microsection, clinical data or endoscopic characteristics. Grades of gastritis 
were classified according to the updated Sydney Classification System [65]. These 
included superficial gastritis, deep chronic gastritis, and chronic atrophic gastritis. 
Diagnoses of superficial gastritis and deep gastritis were merged and termed as 
non-atrophic gastritis (NAG).  
Gastric carcinoma patients were subdivided according to Laurén’s 
classification as carcinomas of the intestinal, diffuse or mixed (atypical) type. Each 
subject was diagnosed based upon the most severe or pronounced finding 
revealed in the pathohistological investigation of the gastric biopsy.  
 
6.2.5 DIAGNOSIS OF H. PYLORI INFECTION 
H. pylori infection was detected by culture, silver stain and PCR for ureB of gastric 
biopsies. Biopsies were considered positive if any of these three tests was positive 
and negative when all three tests were negative. 
 
6.2.5.1 PCR SPECIFIC FOR H. PYLORI UREASE GENE 
Extracted DNA from the antrum tissue sample was used to detect H. pylori with 
PCR using primer specific for a 463-bp segment of the ureB (urease) gene (Table 
6.1). The same mix of reagents was used as for genotype assay (Table 6.5) with 
the following exceptions (Table 6.8): 
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Table 6.8. Regents deviating from genotype assay reaction mixture for PCR 
Reagents Final concentration in 25 µl sample volume 
UreB primer (sense)  0.4 µM 
UreB primer (antisense)  0.4 µM 
MgCl2 2.5 mM 
Taq DNA polymerase 0.02 U 
 
 
PCR was performed using the following cycling parameters (Table 6.9):  
 
Table 6.9. PCR cycling parameters for UreB primer 
1x Denaturation 95 °C 5 min 
35x 
 
Denaturation 95 °C 60 s 
Annealing 
Elongation 
67 °C 
72 °C 
60 s 
60 s 
1x Extenstion 72 °C 5 min 
 
 
6.2.5.2 CULTURING OF H. PYLORI  
One biopsy from the gastric corpus was homogenized and suspension was used 
for H. pylori culture on petri plates containing brain heart infusion (BHI) agar and 
CNA agar. Plates were incubated inverted under microaerophilic conditions (O2, 5 
%; CO2, 10 %; N2, 85 %) at 37ºC and 100 % humidity for 4-7 days by use of BBL 
Campy Pouch Microaerophilic system. When visible colonies appeared (Figure 
6.10), they were identified for H. pylori by positive urease test and Gram`s stain. 
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Figure 6.10:  H. pylori cultured on agar plate. 
 
RAPID UREASE TEST (RUT) 
Urease produced by H. pylori catalyzes the hydrolysis of urea to ammonia. This 
activity of urease can be detected with urea agar base. The resulting ammonia 
raises the pH of the medium which contains phenol red causing a color change 
from yellow to red. The agar base was prepared as follows:  
 Urea agar base (1.5 g) and Bacto Agar (1.5 g) were suspended in 95 ml 
distilled water and dissolved by boiling for 5 min. Agar mix was sterilized by 
autoclaving, and 5 ml sterile 40 % urea solution was added when cooled to 50 °C. 
Urea agar base enriched with 40 % urea was aliquoted in sterile 1.5 ml Eppendorf 
tubes and was allowed to set in the slope position and was refrigerated at 2-8 °C 
prior to use.  
 Colonies that had to be identified from agar plate were placed on urea 
agar base and considered positive when color changed after 20 minutes. 
 
GRAM`S STAIN 
Bacterial cell wall is composed of peptidoglycans that can be penetrated by crystal 
violet, a cationic dye, forming blue-black complexes with iodine in the protoplast 
when flooded with iodine solution. Gram-negative bacteria have a thin 
peptidoglycan wall and an additional layer consisting of lipopolysaccarides that is 
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external to the peptidoglycan wall. Acetone makes the lipopolysaccharide wall 
more permeable and crystal violet can be washed out, allowing subsequent uptake 
of the basic fuchsin stain that gives Gram-negative bacteria (H. pylori) a red color. 
Gram-positive remain blue-black due to the trapped iodine dye complexes in the 
bacterial wall.  
To test colonies, a smear sample was heat fixed on a glass slide and stained as 
follows: 
 
Steps Time 
ddH2O briefly 
Crystal violet  10 s 
ddH2O briefly 
Lugol‘s iodine 10 s 
ddH20 briefly 
Acetone 1-2 s 
Water briefly 
0.25 % Basic fuchsin 15 s 
 
 
6.2.5.2 WARTHIN-STARRY SILVER STAINING 
Warthin-Starry silver staining was additionally performed to Hematoxylin and Eosin 
(HE) staining, using biopsies obtained from the antrum, corpus and incisura 
angularis. 3 µm paraffin sections were deparaffinized, hydrated with deionized 
water and then rinsed in Walpole’s buffer. Slides were covered with 1 % silver 
nitrate and microwaved (600 watts) at a medium setting for 1.5 min and incubated 
in this solution for 5 min. Afterwards, slides were rinsed in Walpole’s buffer (Table 
6.10) and then flooded with freshly prepared developer solution (Table 6.11). 
Warm water was used to rinse slides before dehydrating in two changes of 95 % 
ethanol followed by two changes of absolute ethanol. Finally, slides were cleared 
in xylene and mounted with permount. Each biopsy was scored negative or 
positive for H. pylori and classified for the density of bacteria as low (1, <20 per 
view field), moderate (2, <99) or extensive (3, more >99).  
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Walpole’s buffer was used to solve silver nitrate, gelatine, and hydroquinone.  
Table 6.10. Walpole’s buffer 
Reagents Amount 
5 M acetic acid 17.6 ml 
5 M sodium acetate  12.4 ml 
ddH20 filled up to 500 ml 
 
 
Table 6.11. Developer 
Reagents Amount 
2 % silver nitrate 1.5 ml 
3 % hydroquinone 0.5 ml 
Gelatine  7.5 ml 
 
6.2.6 DATA COLLECTION AND STATISTICAL ANALYSIS 
Data obtained from the questionnaire were entered initially into a Microsoft EXCEL 
database using double data entry, to ensure accurate records. Databases were 
merged and checked for congruence and exported to SPSS for statistical analysis. 
Figure 6.11 shows an overview of procedures done for every case and control who 
participated in this study.  Descriptive statistical analysis was calculated, including 
proportions, percentage, means, and standard deviations. A paired, two-sided t-
test was used to compare differences in continuous variables for paired data. To 
calculate odds ratios (ORs) and 95 % confidence intervals (CIs) for IL-1B-511 and 
IL-1RN genotypes, a conditional logistic regression model was applied, adjusted 
for H. pylori infection. Stratification in an unconditional logistic regression analysis 
was used to evaluate whether the association between the cytokine 
polymorphisms and gastric cancer risk differed by histology type of gastric cancer 
or location of diagnosis. The dependent variable in this study was the histological 
diagnosis. 
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Odds ratios (OR) were estimated under a co-dominant model (homozygote and 
heterozygote genotypes that carry the variant allele versus homozygote wild type, 
the designated reference group). All statistical analyses were performed with 
SPSS software and SPLUS. Differences were considered statistically significant if 
P<0.05. All reported confidence intervals (CIs) are 95 % and P values were 
exclusively two-sided.  
 
 
Figure 6.11: Overview of methods and procedures in the study. 
 
 
HARDY WEINBERG EQUILIBRIUM (HWE) 
The Hardy-Weinberg law suggests no changes for allele and genotype 
frequencies in a population and its successive generations. A deviation from the 
HWE may indicate, for instance, a selection process or gene flow. Hardy-
Weinberg equilibrium of alleles at individual loci was assessed using an internet 
based program available at http://ihg2.helmholtz-muenchen.de/cgi-bin/hw/hwa1.pl.  
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Table 7.12.  Comparison between the two municipal hospitals of Lima regarding age, 
sex, H. pylori infection and diagnoses. All P values were above the 
significant level of 0.05 indicating no significant differences for patients from 
both hospitals. 
 
7.2 CASES AND CONTROLS 
Superficial or deep gastritis were combined to non-atrophic gastritis (NAG) and 
diagnosed for 191 patients that served as control group. Gastric cancer (only 
intestinal and diffuse-type) was histologically confirmed in 179 patients that had a 
mean age not significantly different to the control group (gastric cancer, 61.85 
years; controls, 60.34 years). More women were diagnosed for cancer as well as 
for non-atrophic gastritis and sex ratio revealed no significant difference between 
these two diagnoses (P=0.3) (Table 7.13).  
 49 patients were diagnosed for chronic atrophic gastritis (ChAG) and their 
mean age of 66.9 years significantly differed (P=0.004) from that of controls. In 
addition, more males were found in the case group of ChAG than in controls but 
the difference did not reach a significant level (P=0.054). The proportion of H. 
pylori positive patients was highest in the non-atrophic gastritis group (88 %), 
reflecting the high prevalence of this bacterial infection in Peru. The infection rate 
of H. pylori was lower in patients diagnosed with chronic atrophic gastritis (79.6 %) 
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and even diminished significantly (P=0.001) in the gastric cancer group (74.2 %) 
when compared to non-atrophic gastritis patients.  
 
Table 7.13.  Characteristics of all cases and controls (n=419) that were subjected to 
further analysis. 
 
 
Much of the epidemiological data from the questionnaire showed a significant 
difference between cases and controls as revealed by unconditional logistic 
regression adjusted for age, sex and H. pylori infection (Table 7.14). The 
percentage of gastric cancer patients having no refrigerator (35.7 %) was more 
than two-fold higher than in the control group (15.2 %). A higher percentage was 
also found for chronic atrophic gastritis patients that stored food without cooling 
(22.2 %), but the difference to controls did not reach a significant level. 
Furthermore, a lower percentage of non-atrophic gastritis patients reported lacking 
waste removal by garbage truck (10.6 %) as compared to patients with ChAG 
(18.8 %) and GC (26.4 %). But the difference was only significant for gastric 
cancer patients. In addition, more cases were found to live in rural areas or 
shantytown and boiled water non-standard means as compared to controls. Again, 
significant levels were reached only for gastric cancer cases. Education level and 
materials used for house construction were also different and are displayed in 
Table 7.14. 
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Table 7.14.  Living conditions of all cases and controls (n=419) that were significantly 
different in an unconditional logistic regression model.  
 
 
 
 
Since habit and living circumstances (environmental factors) were different for 
cases and controls (albeit only significant for gastric cancer), controls were 
frequency-matched to cases with respect to environmental factors, age (± 10 
year), and gender. A matching of 1:1 using adequate controls was feasible for 133 
cases with incident non-cardia gastric cancer. Furthermore, appropriate controls 
were available for 43 chronic atrophic gastritis cases to match 2:1 (control:cases). 
Finally, from all non-atrophic gastritis patients, 158 were usable for matching and 
no significant difference regarding environmental factors, age and sex were 
observed between matched groups.  
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A total of 334 patients (NAG, n=158; ChAG, n=43; GC, n=133) were subjected to 
statistical analysis regarding polymorphisms of IL-1B-511 and IL-1RN. Genotype 
frequencies in matched cases and controls did not deviate from the Hardy-
Weinberg equilibrium (Table 7.15). 
 
Table 7.15.  Hardy-Weinberg Equilibrium (HWE) for matched cases and controls. 
 
 
7.3 INCREASED RISK FOR CHRONIC ATROPHIC
 GASTRITIS 
For the IL-1B-511 SNP, 34.9 % of chronic atrophic gastritis patients (cases) and 
64.0 % of patients with non-atrophic gastritis (controls) were homozygous carriers 
of the T allele (Table 7.16). Homozygous carriers of the C allele were very rare in 
controls at 3.5 %. In contrast to studies from Europe and North America, the T 
allele of the IL-1B-511 SNP was more common in controls (80 %). Due to that 
finding, the T allele served as the reference for the calculation of odds ratio (OR) in 
a conditional logistic regression model adjusted for H. pylori infection.  
 The C allele (C/T and C/C genotypes) of the IL-1B-511 SNP was 
associated with a significantly (P=0.001) higher risk for atrophic gastritis (OR, 5.60; 
95 % CI, 2.02-15.51) when compared to non-atrophic gastritis patients (Table 
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7.16). Homozygous carriers of the IL-1B-511 C allele (C/C genotype) even showed 
a higher risk association (OR, 11.2; 95 % CI, 2.27-55.37) for this premalignant 
lesion than patients heterozygous for this allele (OR, 4.8; 95 % CI, 1.65-13.83).  
 
 
Table 7.16.  Homozygous and heterozygous patients with the IL-1B-511 C allele 
showed a significantly higher risk for chronic atrophic gastritis. 
            
 
For the IL-1RN, 4 genotypes (1/1, 1/2, 2/2 and 2/3) were found in the study 
population and alleles *1 and *3 (>2 repeats) were designated as L allele. In 
chronic atrophic gastritis patients and controls, the L allele was more common 
than the *2 allele (allele frequencies: L allele, 62 %; *2 allele, 38 %). The 
heterozygous *2 allele (2/L) was found in 50.0 % of the cases and in 53.5 % of the 
controls. The ratio of homozygous *2 allele carriers was found to be higher for 
cases (19.0 %) than for controls (11.6). However, for the IL-1RN polymorphism, all 
calculated P values were above the significant level of 0.05. There was no 
significant increased risk for chronic atrophic gastritis patients homozygous or 
heterozygous for the *2 allele as compared to patients who were homozygous for 
the L allele (OR, 1.6; 95 % CI, 0.48-5.39 and OR, 1.1; 95 % CI, 0.50-2.48, 
respectively) (Table 7.16).  
It was also examined whether the frequency of the C allele has impact on the 
location of the chronic atrophic gastritis i.e. in the antrum or body (Table 7.17). In 
the antrum region there is a considerably higher risk for chronic atrophic gastritis in 
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patients bearing the IL-1B-511 C allele (OR, 4.0; 95 % CI, 1.63-9.81) as compared 
to the homozygous reference allele variant (genotype T/T). The highest risk for 
chronic atrophic gastritis was found for the homozygous C allele carriers (OR, 
12.7). 
 
 
Table 7.17.  Location of diagnosis. For homozygous IL-1B-511 C allele carriers a 12-fold 
higher risk of getting chronic atrophic gastritis was found, but this 
association was restricted to the antrum.  
            
 
 
7.4 INCREASED RISK FOR GASTRIC CANCER 
Similar to chronic atrophic gastritis, association between the IL-1B-511 SNP and 
gastric cancer was found showing that the homozygous C allele variant of the IL-
1B-511 SNP as well as the heterozygous allele variant were more frequent in 
patients with gastric cancer (OR, 4.15; 95 % CI, 1.33-12.93 and OR, 2.17; 95 % 
CI, 1.23-3.84, respectively) (Table 7.18).  
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Table 7.18. Genotype distribution for NAG and GC. The risk for gastric cancer was 
significantly increased for IL-1B-511 C carriers or for patients homozygous 
for the C allele. 
              
 
 
Cases and controls had similar frequency of homozygous *2 allele carriers      
(12.0 %), and no difference was observed between the two other genotype 
variants (*2/L and L/L). A significant association between gastric cancer risk and 
IL-1RN VNTR could not be reported in this study. For controls, the calculated 
allele frequency for both polymorphisms was as follows: 78 % for the IL-1B-511 T 
allele and 38 % for the IL-1RN *2 allele. 
 Further statistical analysis was conducted for the different histological 
type of gastric cancer (diffuse and intestinal gastric cancer) and location (antrum 
and corpus) to see whether there was a correlation with the distinct 
polymorphisms in the IL-1 gene cluster.  
 Stratification by location and histological type of gastric cancer showed 
that the C allele of the IL-1B-511 SNP was associated with a higher frequency of 
intestinal (OR, 2.6; 95 % CI, 1.0-6.5) but not with diffuse-type of gastric cancer 
(Table 5). The homozygous C allele variant showed a six-fold increased risk of 
intestinal gastric cancer located in the corpus of the stomach compared to non-
atrophic gastritis controls (OR, 6.3; 95 % CI, 1.2-33.8) (Table 7.19). 
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Table 7.19. For homozygous IL-1B-511 C allele carriers a 6-fold higher risk of getting 
intestinal-type gastric cancer was found, but this association was restricted 
to the corpus region.  
 
 
Analysis for the IL-1RN polymorphisms did not show a pronounced increased risk 
of having either intestinal-type or diffuse-type gastric cancer in patients 
homozygous or heterozygous for the *2 allele as compared to patients who were 
homozygous for the L allele. 
7.5 H. PYLORI INFECTION  
The risk of intestinal-type gastric cancer and chronic atrophic gastritis related to IL-
1B-511 genotypes was further examined with stratification by H. pylori infection. 
Analysis revealed a higher risk for chronic atrophic gastritis only for infected 
patients whereas patients homozygous for the C allele of the IL-1B-511 SNP had 
the highest risk compared to patients carrying the heterozygous C allele variant 
(OR, 10.17 and OR, 4.43, respectively) (Table 7.20). 
 Similar, only H. pylori infected patients with the IL-1B-511 C allele variant 
were under a higher risk for intestinal-type gastric cancer as compared to infected 
non-atrophic gastritis patients homozygous for the T allele. The highest risk for 
intestinal-type gastric cancer was found among homozygous C allele carriers (OR, 
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12.24), whereas patients heterozygous for the C allele of the IL-1B-511 SNP 
showed a lower risk (OR, 3.34).  
 
Table 7.20. H. pylori infection and the IL-1B-511 SNP. A significantly higher risk for 
chronic atrophic gastritis or intestinal-type gastric cancer was observed for 
patients infected with H. pylori and bearing the C allele of the IL-1B-511 
SNP.  
 
 
Analysis for H. pylori negative patients did not reveal any increased risk for gastric 
cancer or chronic atrophic gastritis. 
In addition it was questioned whether a distinct allele of the investigated 
polymorphisms is associated with higher risk for H. pylori infection. Analysis 
revealed similar distribution of genotypes for both polymorphisms (IL-1B-511 and 
IL-1RN VNTR) between H. pylori infected and non-infected controls (NAG). 
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8  DISCUSSION 
8.1 STUDY’S MAJOR FINDING 
Given a high load of infection by virulent (cagA positive, vacA toxigenic) H. pylori 
strains in Amerindian Peruvian populations [66], it seems likely that host genetic 
factors affect the risk of emergence and progression of premalignant lesions 
(chronic-atrophic gastritis) in H. pylori-infected Peruvians as in other populations. 
 In the Peruvian study population, a significant association was found 
between the IL-1B-511 SNP and increased risk for chronic atrophic gastritis as 
well as for gastric cancer. The heterozygous C allele variant of the IL-1B-511 SNP 
was associated with a higher risk for chronic atrophic gastritis (OR, 4.79) and 
gastric cancer (OR, 2.17) and highest risk for both pathologies was observed for 
the homozygous C allele variant (ChAG, OR, 11.22 and GC, OR, 4.15). 
Stratification by disease location revealed significant associations for ChAG in the 
antrum region and for intestinal-type gastric cancer in the corpus. 
 The findings of the present study confirm and extend the previous 
observation that SNPs as a host factor are involved in the susceptibility of 
intestinal-type gastric cancer and its precancerous lesion, e.g. atrophic gastritis, in 
H. pylori-infected patients. Furthermore, it suggests a different mechanism in the 
carcinogenesis of diffuse-type gastric cancer. In addition, this study is the first to 
verify the C allele of the IL-1B-511 SNP as a risk factor in a population from South-
America.  
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8.2 STUDY DESIGN 
A case-control study was used to compare exposure to genetic risk factors          
(IL-1B-511 SNP, IL-1RN VNTR) between non-atrophic gastritis patients as 
controls and individuals diagnosed with chronic atrophic gastritis or gastric cancer. 
Since H. pylori prevalence is very high in Peru [67], histological findings of healthy 
gastric mucosa are very rare and appropriate selection of controls was assumed 
by non-atrophic gastritis patients. The use of uninfected healthy controls would 
lead to an overestimation of the effect of genetic variants in the IL-1ß gene cluster 
due to the marked impact of H. pylori on gastric mucosal changes [68]. Cases of 
gastric cancer or ChAG represented a subset of all patients admitted to the 
affiliated hospitals and therefore controls were sampled from the same institution.  
 Recently it has been shown in a study from Peru, that H. pylori infection 
rate is linked to water supply, level of hygiene and sanitation especially among 
children [69] and also depends on socioeconomic status [8;10]. Assuming that 
patients differed with regards to their socioeconomic level and environmental 
factors, a 130-item questionnaire was achieved from every patient to test for 
homogeneity in cases and controls. In the present study environmental factors 
showed a significant association with gastric cancer risk. Especially the lack of 
regular waste removal was more common for gastric cancer cases than for non-
atrophic gastritis patients. In addition, more cases had no refrigerator and did not 
boil water in a standard fashion.  
 This suggests that the outcome of a H. pylori infection is modulated in part 
by living circumstances and habits of the infected host. Therefore, cases and 
controls were matched to yield the required homogeneity in the study population. 
Homogenous genetic background between patients from both municipal hospitals 
was assumed since all individuals were Mestizos. 
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8.3 ALLELE FREQUENCIES 
Comparison of the T allele frequency in healthy and non-atrophic gastritis patients 
from different studies (Figure 2.1) showed that the T allele of the IL-1B-511 SNP is 
more frequent in Asians and South Americans (45 % - 55 %). The present study 
observed an even higher frequency of around 80 % in non-atrophic gastritis 
patients. Due to that finding, the T allele served as a reference allele variant for 
subsequent statistical analysis. To date, this is the highest reported frequency for 
the IL-1B-511 T allele. RFLP technique was used for genotyping and the accuracy 
of assay was controlled by reanalyzing one fifth of samples from the preceding 
setting in the subsequent run. Furthermore, several samples were sequenced for 
the SNP and for each run all genotype variants (C/C, C/T, T/T) were included as 
positive controls. Since genotypes of all reanalyzed samples were concordant, a 
proper working assay can be assumed.  
 The *2 allele of the IL-1RN VNTR showed higher frequency (38 %) in 
comparison to reports from Asia but similar to the studies from Europe (22 % -    
46 %). Taken together, the allele frequencies of the IL-1RN VNTR were 
comparable to European populations whereas the IL-1B-511 SNP alleles showed 
frequencies more similar to that of Asian populations. Reported allele frequencies 
from the present study are interesting, since the study’s population consisted of 
Mestizos, a mixed population of Amerindians and Europeans, whereas 
Amerindians have ancestors from Central Asia.  
 
8.4 POLYMORPHISMS IN THE IL-1B GENE 
 CLUSTER  
It has recently been suggested that interaction between bacterial virulence factors 
and immune response of the host affect the outcome of H. pylori infection and may 
be influenced by polymorphisms in both bacterium and host [36;70]. Especially 
polymorphisms in IL-1B and IL-1RN genes were found to be associated with a 
higher risk for gastric cancer development due to increased IL-1ß level in gastric 
mucosa in response to H. pylori infection [36;71]. El-Omar et al. described SNPs in 
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the IL-1B gene at positions -511, -31, +3954 bp from the transcriptional start site 
and showed significant associations to H. pylori-associated gastric cancer only for 
the first two positions [26]. Since these two regions are in total linkage 
disequilibrium, this thesis focused on the IL-1B-511 SNP. 
8.4.1 HIGHER RISK FOR CHAG AND GC 
The present study revealed a significant association between the IL-1B-511 C 
allele gastric cancer and its premalignant lesion, chronic atrophic gastritis. This is 
in line with studies from Japan and China that reported a similar association for the 
C allele [44;48] and that the C/C genotype is more frequent in low acid        
producers [63]. Inflammation in the stomach induced by H. pylori infection 
correlates with high IL-1ß level [72] which triggers immune response. Furthermore, 
enhanced IL-1ß level in gastric mucosa continuously increases the pH by inhibiting 
gastric acid production in the stomach, paving the way for progressive mucosal 
changes with a subsequent increased risk for gastric carcinogenesis. 
 Since chronic atrophic gastritis was associated with the IL-1B-511 C allele 
in the present study, Peruvians bearing the C allele might have high mucosal IL-1ß 
levels resulting in lower gastric acid output (hypochlorhydria). This has to be 
confirmed in further studies by measuring gastric output and mRNA of IL-1ß in 
non-atrophic gastritis patients.  
 The heterozygous genotype (C/T) showed a significant association with 
chronic atrophic gastritis as well as gastric cancer (OR, 4.79 and 2.17, 
respectively). Homozygosity for the C allele of the IL-1B-511 SNP was even more 
strongly associated with both pathologies, ChAG (OR, 11.2) and GC (OR, 4.15). 
The increasing odds ratio from heterozygous to homozygous carriers of the C 
allele suggests an additive effect of this polymorphism on the IL-1ß level.  
 These findings differ from those of previous studies in which the opposite 
allele (T allele) of the IL-1B-511 SNP was noted as a risk factor for chronic 
atrophic gastritis and gastric cancer [26;29;36;37]. However, most of these studies 
were conducted in Caucasian populations that showed a lower T allele frequency 
(<38 %) than frequencies found for Asians (45-55 %). In the Peruvian population, 
the T allele frequency was observed to be around 80 % which is more similar to 
that of Asians. That may in part be due the Amerindians with origins in Central 
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Asia, still reflecting the genetic background [9]. The even higher frequency of the T 
allele in comparison to Asians might be due to selective pressure on genotypes of 
Peruvian population.   
8.4.2 LOCATION OF DIAGNOSIS AND GASTRIC CANCER 
 SUBTYPES 
Given the fact that antrum and corpus region differ in their function and cell 
composition, it was further investigated whether there is a marked difference in the 
effect of the C allele on gastric cancer subtypes and location of histological 
diagnosis. Indeed, a higher risk was found for intestinal-type gastric cancer in 
corpus (OR 6.29) for patients bearing the homozygous IL-1B-511 C allele variant. 
In addition, chronic-atrophic gastritis was more frequent in antral gastric biopsies 
and only in this region was a higher risk for atrophy associated with the IL-1B-511 
C allele (OR 12.72).  
 One explanation could be the low prevalence of atrophy detected in the 
corpus, but, on the other hand, the H. pylori infection might start in the antrum or 
be restricted to the antrum due to intact corpus mucosa characterized by normal 
gastric acid output. The observed higher frequency of antrum atrophic gastritis has 
also been reported by previous studies from Peru [67;73;74].  
Specialized cells of the stomach mucosa control gastric acid stimulation 
and secretion. While the hormone gastrin is released in the antrum region by G 
cells, enterochromaffine-like cells (ECL) in the corpus region respond with cell 
growth and the release of histamine [75;76]. Histamine from ECL cells together 
with gastrin from G cells stimulates parietal cells in the corpus to secrete gastric    
acid [77]. Deregulation can occur in this circuit if stomach is infected with H. pylori 
whereas alteration of acid secretion also depends on affected cells. Mostly, the 
inflammatory process starts in the antrum and affects inhibitory somatostatin cells, 
leading to higher gastrin levels and increased acid secretion in the corpus. High 
acid secretion hinders H. pylori colonization of the corpus and restricts the 
inflammation to the antral region. This pattern is also seen in duodenal ulcers, 
where a healthy corpus continues to secret gastric acid which is responsible for 
the epithelial damage in the duodenum. If H. pylori gastritis affects the corpus 
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region with its parietal cells, gastric secretion is decreased, which leads to higher 
pH. These are excellent conditions for further colonization of H. pylori and 
maintenance of the infection and can subsequently lead to atrophy in the corpus. 
 Once H. pylori gastritis affects the corpus region, inflammatory cytokines 
(IL-1ß and TNFα) can inhibit acid-secreting parietal cells, leading to a reduced 
gastric acid secretion [28]. The C allele may lead to an even higher IL-1ß level and 
subsequent enhanced acid reduction. 
Gastric mucosa attempts to adjust the decreased acid output by enhanced 
gastrin secretion that stimulates parietal cells. Since the corpus is inflamed and 
parietal cell function is decreased, acid output remains low, leading to pronounced 
atrophy in the corpus. Sustained inflammation and high gastrin levels act as a 
proliferative stimulus on epithelial cell [27] and, in combination with reactive 
oxygen species (ROS), bacterial overgrowth, and nitrosamines, lead to an 
increased risk of DNA damage, mutagenesis and progression to carcinogenesis.  
This is confirmed by the present finding that patients with the C allele were 
under significantly higher risk for intestinal-type gastric cancer only in the corpus. 
The different impact of the IL-1B-511 SNP to the IL-1ß level in antrum and corpus 
in response to H. pylori infection has to be considered as an underlying 
mechanism. This is supported by a previous study showing higher mucosal IL-1ß 
levels in the gastric body than in the antrum region of patients with the IL-1B -511 
SNP C allele [72].  
In this regard, the atrophy in the antrum could be interpreted as a first step 
in a multistage progression that can lead to H. pylori colonization of the corpus as 
well, along with an increased risk of intestinal-type gastric cancer in patients 
bearing the IL-1B-511 C allele.  
8.4.3 THE IL-1RN VNTR  
The second investigated host gene, IL-1RN, encodes for the IL-1ra protein, 
showing the same affinity as IL-1ß to the corresponding receptor (IL-1R). Since IL-
1ra does not induce any intracellular response, it is acting in a competitive manner 
with respect to IL-1ß and thereby subsequently modulates the proinflammatory 
effects of IL-1ß [32].  
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The *2 allele of the VNTR in the intron 2 has been linked to higher IL-1ß 
production in vitro [33] and seems to be associated with atrophic gastritis [36] and 
early-stage gastric cancer [78]. 
 The present study has not revealed any significant association between 
the IL-1RN VNTR and atrophic gastritis, similar to several studies from Asia. In 
contrast, especially studies with Caucasian populations have reported a significant 
association between the IL-1RN *2 allele and outcome of H. pylori infection (i.e. 
chronic atrophic gastritis, gastric cancer). The difference between the present 
findings and those from Europe might depend on the regulative role of IL-1ra to IL-
1ß. IL-1ra and IL-1ß might act hand in hand, so that increasing IL-1ra level would 
provoke an enhanced IL-1ß level to maintain a given IL-1ß/IL-1ra ratio. Virulence 
factors of H. pylori along with the SNP at IL-1B-511 may cause such a high basal 
IL-1ß level and/or prolonged effects of IL-1ß that diminish the importance of IL-1ra 
variants as regulators of the IL-1ß synthesis in the Peruvian population. 
Furthermore, if the 3 different genotypes (*2/*2, *2/L, L/L) in Peruvians cause 
same IL-1ra protein level, no alteration in the IL-1ß level would succeed and might 
also explain the lacking association.  
 Taken together, the above-mentioned findings suggest that this distinct 
SNP and its association with a higher risk for ChAG and GC is population-specific 
and depends on the allele frequency in the study population.  
 
8.5 H. PYLORI INFECTION 
H. pylori infected and non-infected controls (NAG) showed similar distribution of 
genotypes for both polymorphisms (IL-1B-511 and IL-1RN VNTR). Thus, neither 
the IL-1B SNP nor the IL-1RN VNTR were associated with a higher risk for H. 
pylori infection, which itself is a risk factor for chronic atrophic gastritis and gastric 
cancer [68]. This suggests that the observed association between the IL-1B SNP 
and higher risk for both gastric diseases are caused by the impact of the C allele 
rather than by increased susceptibility for H. pylori. 
 Blaser and Atherton [79] proposed a mathematical model that describes 
the equilibrium between colonized bacterium and gastric mucosa of the host 
whereas cross talk occurs by direct contact or soluble mediators. When activation 
of the host’s immune response disturbs equilibrium, H. pylori infection may persist 
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due to selective mechanism for the fittest bacterium or due to altered protein 
secretion by the bacterium itself. Achieving a new equilibrium level maintains the 
chronic bacterial infection without impairment of colonization conditions for H. 
pylori in the gastric mucosa. This assumption is supported by epidemiological 
studies from Peru where about one-half of Peruvian children become infected with 
H. pylori during their first years, and most others become infected within the 
following next one to two decades [18;19], suggesting a lifelong infection in this 
population.  
 The proportion of H. pylori-positive patients was highest in the non-
atrophic gastritis group (88 %), reflecting the high prevalence of this bacterial 
infection in Peruvian gastritis patients. These findings are in line with previous 
reports from Peru claiming that nearly 90 % of adults undergoing upper-
gastrointestinal endoscopy due to dyspeptic symptoms were found to be infected 
with this bacterium [14;15]. The lower rate of H. pylori infection was revealed for 
the chronic atrophic gastritis patients (79.6 %) and for gastric cancer group     
(74.2 %). Since atrophic gastritis or cancerous mucosa is unsuitable for H. pylori 
colonization [23], it is possible that some H. pylori-negative cases had previously 
been infected.  
 However, the observed decrease in H. pylori prevalence in ChAG and GC 
underlines the fact that worsen mucosal conditions cause disbalance between a 
host’s gastric mucosa and bacteria. H. pylori itself and an atrophic mucosal 
environment can lead to DNA damage in gastric epithelial cells [80], optimal 
conditions for carcinogenic process.  
 
8.6 CONCLUSION 
To summarize, the following conclusion can be drawn based on previous and 
present findings:  
 H. pylori infection in combination with a functional IL-1B variant can lead 
to increased IL-1ß secretion and subsequent decline of gastric acid secretion. 
Restriction of the bacterial infection to the antrum region is associated with normal 
gastric acid output but higher a risk for antral atrophic gastritis. Once H. pylori 
infection encroaches upon the corpus region, inflammation subsequently leads to 
higher risk for intestinal-type gastric cancer. 
 58 discussion 
This study is the first to establish the C allele of the IL-1B-511 SNP as a risk factor 
for intestinal-type gastric cancer and its premalignant lesion gastric atrophy in a 
largely Amerindian population. These findings are consistent with the progression 
of histological changes from chronic atrophic gastritis to intestinal-type gastric 
cancer. Furthermore, it suggests differences in processes leading to diffuse-type 
gastric cancer. 
 In conjunction with previous studies, our results show the importance of 
population-based SNP investigations regarding gastric cancer risk. Our findings 
support the hypothesis that inter-individual, genetically determined differences of 
cytokine production affect outcomes of H. pylori infection and gastric cancer risk. 
In view of a high H. pylori prevalence and a high recurrence rate of treated 
infection in Peruvians with low socioeconomic status [20], IL-1B-511 SNP might be 
an indicator for patients who will benefit from rigorous anti H. pylori therapy and 
intensive surveillance of gastric mucosal changes by means of intermittent 
gastroscopies.  
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